Insightcast AI
Home
Login
Closing Bell Overtime: CRISPR Therapeutics CEO On Milestone FDA Approval; Rick Caruso On Potential Macy’s Sale 12/11/23
Closing Bell XX
--:--
--:--
Mark
No transcription available